Therapeutic Use (Phase IV)

1,197 trials 558 recruiting

Filter these 1,197 trials by condition, country, sponsor and more.

Open in Search →

A study to learn about the blood levels of aflibercept when high-dose aflibercept is injected in both eyes of participants with diabetic mac… Ended

2024-511665-11-00 Neovascular age-related macular degeneration (nAMD) 2024-08-29
A blinded randomized study of two types of reversal agents (neostigmine/glycopyrrolate 50 mikrogram/kg or sugammadex 2 mg/kg) for reversal o… Ended

2023-504230-21-00 Anaesthesia to laparoscopic robotassisted surgery 2024-08-12
European randomised clinical trial on mPOX Infection (EPOXI) Ended

2022-501979-10-00 Monkeypox 2024-08-08
Personalized Treatment Optimization for Kidney Health in Type 2 Diabetes: A Remote Trial with Empagliflozin and Finerenone Ended

2023-508585-15-00 Albuminuria 2024-07-29
Cardiodoron® vs. placebo for functional cardiovascular disorders (FCD) Ended

2024-511210-21-00 functional cardiovascular disorders 2024-07-23
COmparison of Bleeding Risk between Rivaroxaban and Apixaban for the treatment of acute venous thromboembolism Ended

2023-504179-26-00 Acute Venous Thromboembolism 2024-07-19
Optimization of the management of drepanocytosis patients treated with hydroxyurea: Interest of the pharmacological therapeutic follow-up Ended

2024-515562-14-00 Drepanocytosis 2024-07-19
Understanding the Neurobiology of Pharmacologically-induced Acute Stress on Ethical Decisions Ended

2023-508731-31-01 Mimic an acute stress response in humans. 2024-07-18
A Phase 4 Multicenter, Randomized, Open-label, Efficacy Assessor-blinded Study of Risankizumab Compared to Deucravacitinib for the Treatment… Ended

2023-509738-20-00 Plaque Psoriasis 2024-07-11
GO TEST FINALE Ended

2024-511111-13-01 Gout 2024-07-09
A randomized, multicenter, open-label trial comparing the effectiveness of Inclisiran to bempedoic acid on LDL cholesterol (LDL-C) lowering … Ended

2024-511076-32-00 Hypercholesterolemia 2024-06-21
Efficacy of Intrathecal Morphine for Postoperative Analgesia with or without Suprainguinal Fascia Iliaca Block After Total Hip Arthroplasty:… Ended

2024-511946-38-00 Total hip arthroplasty under spinal anesthesia 2024-06-12
Duration of peripheral nerve blocks in opioid tolerant individuals Ended

2023-509351-13-00 Postoperative pain 2024-06-11
Comparative analysis of the effectiveness and security of the blockade Erectus Spinae Plane Lumbar (ESP-L) versus the absence of locoregiona… Ended

2024-511528-15-00 Hip fracture 2024-06-02
Nitrous oxide abuse in traffic – A clinical study of the blood concentrations and driving ability during and after short recreational intake… Ended

2023-509993-49-00 Recreational use while driving a vehicle. Healthy volun 2024-05-19
Effect of Dupilumab on nasal epithelial barrier function in patients with Chronic Rhinosinusitis with nasal polyps (CRSwNP) – an exploratory… Ended

2023-509815-10-00 Chronic rhinosinusitis with nasal polyps 2024-05-15
Phenosar Ended

2024-513534-38-00 sarcoidosis 2024-05-13
VENLID Ended

2023-507859-29-00 Pain 2024-05-07
Maternal pertussis immunization in Finland, 4 years (MIFI-4Y) Ended

2024-510787-23-00 Pertussis 2024-05-07
dTap booster vaccination of health care workers (HC dTap) Ended

2024-511478-56-00 Diphtheria, tetanus, pertussis (wooping cough) 2024-05-03
PHARMACOKINETICS OF CEFEPIME AFTER INTRAPERITONEAL ADMINISTRATION VIA CYCLER-THERAPY IN APD PATIENTS WITHOUT PERITONITIS Ended

2023-509930-21-00 CKD 5, Peritoneal Dialysis 2024-05-01
Rapid pain control in Ixekizumab targeted axial spondyloarthritis Ended

2023-508976-12-00 axial spondyloarthritis 2024-04-29
LIC-block with Lidocaine or Ropivacaine for closed reduction of wrist fracture Ended

2024-510572-20-00 Distal radius fractures with need of acute closed reduc 2024-04-23
Long Term Outcomes Ended

2023-505098-34-00 Opioid Use Disorder 2024-04-22